The C-type lectin Clec12A present on mouse and human dendritic cells can serve as a target for antigen delivery and enhancement of antibody responses

Journal of Immunology

Volumn 182, Issue 12, 2009, Pages 7587-7594

  Lahoud, Mireille H ^a   Proietto, Anna I ^a   Ahmet, Fatma ^a   Kitsoulis, Susie ^a   Eidsmo, Liv ^b   Wu, Li ^a   Sathe, Priyanka ^a   Pietersz, Suzanne ^c   Chang, Hsuen Wen ^d   Walker, Ian D ^e   Maraskovsky, Eugene ^f   Braley, Hal ^f   Lew, Andrew M ^a   Wright, Mark D ^g   Heath, William R ^h   Shortman, Ken ^a   Caminschi, Irina ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b KAROLINSKA INSTITUTE   (Sweden)

^c IP Australia   (Australia)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e CSL ^*  (Australia)

^f CSL   (Australia)

^g MONASH UNIVERSITY   (Australia)

^h UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; CD8 ANTIGEN; HYBRID PROTEIN; IMMUNOGLOBULIN; LECTIN; LIPOPOLYSACCHARIDE; PROTEIN CLEC12A; UNCLASSIFIED DRUG; CLEC12A PROTEIN, HUMAN; CLEC12A PROTEIN, MOUSE; LECTIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; T LYMPHOCYTE ACTIVATION; ANIMAL; ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; CELL CULTURE; CELL MEMBRANE; HUMAN; IMMUNOLOGY; LEUKOCYTE;

ANIMALS; ANTIBODY FORMATION; ANTIGEN PRESENTATION; ANTIGENS; CELL MEMBRANE; CELLS, CULTURED; DENDRITIC CELLS; HUMANS; LECTINS, C-TYPE; LEUKOCYTES; MICE; RECEPTORS, MITOGEN;

EID: 67649184779     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900464     Document Type: Article

References (38)

1. Kawai, T., and S. Akira. 2007. TLR signaling. Semin. Immunol. 19: 24-32.
2. Robinson, M. J., D. Sancho, E. C. Slack, S. LeibundGut-Landmann, and C. Reis e Sousa. 2006. Myeloid C-type lectins in innate immunity. Nat. Immunol. 7: 1258-1265.
3. Cambi, A., M. Koopman, and C. G. Figdor. 2005. How C-type lectins detect pathogens. Cell Microbiol. 7: 481-488.
4. Bakker, A. B., S. van den Oudenrijn, A. Q. Bakker, N. Feller, M. van Meijer, J. A. Bia, M. A. Jongeneelen, T. J. Visser, N. Bijl, C. A. Geuijen, et al. 2004. C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemia. Cancer Res. 64: 8443-8450.
5. Chen, C. H., H. Floyd, N. E. Olson, D. Magaletti, C. Li, K. Draves, and E. A. Clark. 2006. Dendritic-cell-associated C-type lectin 2 (DCAL-2) alters dendritic-cell maturation and cytokine production. Blood 107: 1459-1467.
6. Marshall, A. S., J. A. Willment, H. H. Lin, D. L. Williams, S. Gordon, and G. D. Brown. 2004. Identification and characterization of a novel human myeloid inhibitory C-type lectin-like receptor (MICL) that is predominantly expressed on granulocytes and monocytes. J. Biol. Chem. 279: 14792-147802.
7. Pyz, E., C. Huysamen, A. S. Marshall, S. Gordon, P. R. Taylor, and G. D. Brown. 2008. Characterization of murine MICL (CLEC12A) and evidence for an endogenous ligand. Eur. J. Immunol. 38: 1157-1163.
8. Han, Y., M. Zhang, N. Li, T. Chen, Y. Zhang, T. Wan, and X. Cao. 2004. KLRL1, a novel killer cell lectinlike receptor, inhibits natural killer cell cytotoxicity. Blood 104: 2858-2866.
9. Weis, W. I., M. E. Taylor, and K. Drickamer. 1998. The C-type lectin superfamily in the immune system. Immunol. Rev. 163: 19-34.
10. Marshall, A. S., J. A. Willment, E. Pyz, K. M. Dennehy, D. M. Reid, P. Dri, S. Gordon, S. Y. Wong, and G. D. Brown. 2006. Human MICL (CLEC12A) is differentially glycosylated and is down-regulated following cellular activation. Eur. J. Immunol. 36: 2159-2169.
11. - dendritic cells. J. Immunol. 177: 372-382.
12. Boyle, J. S., A. Silva, J. L. Brady, and A. M. Lew. 1997. DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity. Proc. Natl. Acad. Sci. USA 94: 14626-14631.
13. Vremec, D., J. Pooley, H. Hochrein, L. Wu, and K. Shortman. 2000. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 164: 2978-2986. (Pubitemid 30148956)
14. Caminschi, I., F. Ahmet, K. Heger, J. Brady, S. L. Nutt, D. Vremec, S. Pietersz, M. H. Lahoud, L. Schofield, D. S. Hansen, et al. 2007. Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells. J. Exp. Med. 204: 2579-2590.
15. Bourges, D., Y. Zhan, J. L. Brady, H. Braley, I. Caminschi, S. Prato, J. A. Villadangos, and A. M. Lew. 2007. Targeting the gut vascular endothelium induces gut effector CD8 T cell responses via cross-presentation by dendritic cells. J. Immunol. 179: 5678-5685.
16. White, P. J., F. Anastasopoulos, J. E. Church, C. Y. Kuo, B. J. Boyd, P. L. Hickey, L. S. Tu, P. Burns, A. M. Lew, W. R. Heath, et al. 2008. Generic construction of single component particles that elicit humoral and cellular immune responses without the need for adjuvants. Vaccine 26: 6824-6831.
17. Galibert, L., G. S. Diemer, Z. Liu, R. S. Johnson, J. L. Smith, T. Walzer, M. R. Comeau, C. T. Rauch, M. F. Wolfson, R. A. Sorensen, et al. 2005. Nectin-like protein 2 defines a subset of T-cell zone dendritic cells and is a ligand for class-I-restricted T-cell-associated molecule. J. Biol. Chem. 280: 21955-21964.
18. Wang, H., M. N. Griffiths, D. R. Burton, and P. Ghazal. 2000. Rapid antibody responses by low-dose, single-step, dendritic cell-targeted immunization. Proc. Natl. Acad. Sci. USA 97: 847-852.
19. + T cell responses through in vivo targeting of antigen to dendritic cell-associated C-type lectin-1. J. Immunol. 177: 2276-2284.
20. - dendritic cell subset induces humoral immunity in the absence of conventional "danger." Eur. J. Immunol. 35: 2815-2825.
21. Bonifaz, L. C., D. P. Bonnyay, A. Charalambous, D. I. Darguste, S. Fujii, H. Soares, M. K. Brimnes, B. Moltedo, T. M. Moran, and R. M. Steinman. 2004. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 199: 815-824.
22. Boscardin, S. B., J. C. Hafalla, R. F. Masilamani, A. O. Kamphorst, H. A. Zebroski, U. Rai, A. Morrot, F. Zavala, R. M. Steinman, R. S. Nussenzweig, and M. C. Nussenzweig. 2006. Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses. J. Exp. Med. 203: 599-606.
23. Finkelman, F. D., A. Lees, R. Birnbaum, W. C. Gause, and S. C. Morris. 1996. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J. Immunol. 157: 1406-1414.
24. Tacken, P. J., I. J. de Vries, R. Torensma, and C. G. Figdor. 2007. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat. Rev. Immunol. 7: 790-802.
25. Delneste, Y., G. Magistrelli, J. Gauchat, J. Haeuw, J. Aubry, K. Nakamura, N. Kawakami-Honda, L. Goetsch, T. Sawamura, J. Bonnefoy, and P. Jeannin. 2002. Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 17: 353-362.
26. + dendritic cells. J. Immunol. 180: 3201-3209.
27. Caminschi, I., A. I. Proietto, F. Ahmet, S. Kitsoulis, J. Shin Teh, J. C. Lo, A. Rizzitelli, L. Wu, D. Vremec, S. L. van Dommelen, et al. 2008. The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood 112: 3264-3273.
28. + T cells by exogenous cell-associated antigens. Immunity 17: 211-220.
29. +, T cells by plasmacytoid dendritic cells. J. Exp. Med. 204: 1923-1933.
30. Probst, H. C., K. Tschannen, B. Odermatt, R. Schwendener, R. M. Zinkernagel, and M. Van Den Broek. 2005. Histological analysis of CD11c-DTR/GFP mice after in vivo depletion of dendritic cells. Clin. Exp. Immunol. 141: 398-404.
31. - dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192: 1685-1696.
32. + dendritic cells. J. Immunol. 166: 5327-5330.
33. Geijtenbeek, T. B., D. J. Krooshoop, D. A. Bleijs, S. J. van Vliet, G. C. van Duijnhoven, V. Grabovsky, R. Alon, C. G. Figdor, and Y. van Kooyk. 2000. DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking. Nat. Immunol. 1: 353-357.
34. Geijtenbeek, T. B., R. Torensma, S. J. van Vliet, G. C. van Duijnhoven, G. J. Adema, Y. van Kooyk, and C. G. Figdor. 2000. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100: 575-585.
35. Van Vliet, S. J., J. den Dunnen, S. I. Gringhuis, T. B. Geijtenbeek, and Y. van Kooyk. 2007. Innate signaling and regulation of dendritic cell immunity. Curr. Opin. Immunol. 19: 435-440.
36. Brown, G. D., and S. Gordon. 2001. Immune recognition: a new receptor for β-glucans. Nature 413: 36-37.
37. Rogers, N. C., E. C. Slack, A. D. Edwards, M. A. Nolte, O. Schulz, E. Schweighoffer, D. L. Williams, S. Gordon, V. L. Tybulewicz, G. D. Brown, and C. Reis e Sousa. 2005. Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity 22: 507-517.
38. Burgdorf, S., A. Kautz, V. Bohnert, P. A. Knolle, and C. Kurts. 2007. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science 316: 612-616.